Carma1 (also known as caspase recruitment domain [CARD]11, Bimp3) is a CARD-containing membrane-associated guanylate kinase family protein that plays an essential role in antigen receptor–induced nuclear factor κB activation. We investigated the role of Carma1 in the assembly of signaling molecules at the immune synapse using a peptide-specific system. We report that Carma1 is essential for peptide-induced interleukin 2 and interferon γ production, but dispensable for proliferation in T cells. Recruitment and distribution of T cell receptor, lymphocyte function associated 1, lipid rafts, and protein kinase C (PKC)θ to central and peripheral immune synapse regions occur normally in Carma1−/− T cells. Carma1 controls entry of IκB kinase (IKK) into lipid raft aggregates and the central region of the immune synapse, as well as activation of IKK downstream of PKC. Our data provide the first genetic evidence on a new class of molecular scaffold that controls entry of defined signaling components, IKK, into the central supramolecular activation cluster at T cell–antigen-presenting cell interfaces without having any apparent effect on the overall organization and formation of immune synapses.
Skip Nav Destination
Article navigation
1 November 2004
Article|
November 01 2004
The Molecular Adapter Carma1 Controls Entry of IκB Kinase into the Central Immune Synapse
Hiromitsu Hara,
Hiromitsu Hara
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
3Laboratory for Cell Signaling, RIKEN Research Center for Allergy and Immunology, Yokohama 230-0045, Japan
Search for other works by this author on:
Christopher Bakal,
Christopher Bakal
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Teiji Wada,
Teiji Wada
1IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, A-1030 Vienna, Austria
Search for other works by this author on:
Denis Bouchard,
Denis Bouchard
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Robert Rottapel,
Robert Rottapel
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Takashi Saito,
Takashi Saito
3Laboratory for Cell Signaling, RIKEN Research Center for Allergy and Immunology, Yokohama 230-0045, Japan
Search for other works by this author on:
Josef M. Penninger
Josef M. Penninger
1IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, A-1030 Vienna, Austria
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Hiromitsu Hara
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
3Laboratory for Cell Signaling, RIKEN Research Center for Allergy and Immunology, Yokohama 230-0045, Japan
Christopher Bakal
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Teiji Wada
1IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, A-1030 Vienna, Austria
Denis Bouchard
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Robert Rottapel
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Takashi Saito
3Laboratory for Cell Signaling, RIKEN Research Center for Allergy and Immunology, Yokohama 230-0045, Japan
Josef M. Penninger
1IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, A-1030 Vienna, Austria
2Ontario Cancer Institute, University Health Network, and Department of Medical Biophysics and Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Address correspondence to Josef M. Penninger, IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, c/o Dr. Bohr Gasse 3-5, A-1030 Vienna, Austria. Phone: 43-1-79730-454; Fax: 43-1-79730-459; email: [email protected]
Abbreviations used in this paper: CARD, caspase recruitment domain; cSMAC, central supramolecular activation cluster; CTx, cholera toxin; DIM, detergent insoluble material; IKK, IκB kinase; MAGUK, membrane-associated guanylate kinase; PKC, protein kinase C; pSMAC, peripheral supramolecular activation cluster; SMAC, supramolecular activation cluster; Tg, transgenic.
Received:
December 29 2003
Accepted:
August 20 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 200 (9): 1167–1177.
Article history
Received:
December 29 2003
Accepted:
August 20 2004
Citation
Hiromitsu Hara, Christopher Bakal, Teiji Wada, Denis Bouchard, Robert Rottapel, Takashi Saito, Josef M. Penninger; The Molecular Adapter Carma1 Controls Entry of IκB Kinase into the Central Immune Synapse . J Exp Med 1 November 2004; 200 (9): 1167–1177. doi: https://doi.org/10.1084/jem.20032246
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement